Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms for estrogen receptor expression in human cancer
Hui Hua, Hongying Zhang, Qingbin Kong, et al.
Experimental Hematology and Oncology (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Complex roles of cAMP–PKA–CREB signaling in cancer
Hongying Zhang, Qingbin Kong, Jiao Wang, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 331
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Shenghong Ma, Tracy Tang, Gary D. Probst, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96
The Influence of Sex Hormones in Liver Function and Disease
Alvile Kasarinaite, Matthew C. Sinton, Philippa T. K. Saunders, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1604-1604
Open Access | Times Cited: 49
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance
Jing Wang, Baizhou Li, Meng Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Mohammad Mijanur Rahman, Andrew C. Brane, Trygve O. Tollefsbol
Cells (2019) Vol. 8, Iss. 10, pp. 1214-1214
Open Access | Times Cited: 100
Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment
Nida Pasha, Nicholas C. Turner
Nature Cancer (2021) Vol. 2, Iss. 7, pp. 680-692
Closed Access | Times Cited: 88
Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
Simon P. Langdon, C. Simon Herrington, Robert L. Hollis, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1647-1647
Open Access | Times Cited: 85
Carcinogenic effects of bisphenol A in breast and ovarian cancers (Review)
Mihai Cristian Dumitrașcu, Cristian Mareș, Răzvan Petca, et al.
Oncology Letters (2020) Vol. 20, Iss. 6, pp. 1-1
Open Access | Times Cited: 73
Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
Sulltana Jahan, Md. Emranul Karim, Ezharul Hoque Chowdhury
Biomedicines (2021) Vol. 9, Iss. 2, pp. 114-114
Open Access | Times Cited: 63
Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
Aditi S. Khatpe, Adedeji K. Adebayo, Christopher Herodotou, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 369-369
Open Access | Times Cited: 61
Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study
Manar G. Salem, Dina M. Abu El-Maaty, Yassmina I. Mohey El-Deen, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4898-4898
Open Access | Times Cited: 40
Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression
Kang Shen, Huiguang Yu, Baohua Xie, et al.
Pharmacology & Therapeutics (2023) Vol. 242, pp. 108350-108350
Closed Access | Times Cited: 24
Receptor-Targeted Nanomedicine for Cancer Therapy
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 12
Drug-Target Interactions Prediction Based on Signed Heterogeneous Graph Neural Networks
Ming Chen, Yajian Jiang, Xiujuan Lei, et al.
Chinese Journal of Electronics (2024) Vol. 33, Iss. 1, pp. 231-244
Open Access | Times Cited: 9
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases
Ana Božović, Vesna Mandušić, Lidija Todorović, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1656-1656
Open Access | Times Cited: 52
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions
Fulvio Borella, Andrea Roberto Carosso, Stefano Cosma, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 5, pp. 987-1009
Closed Access | Times Cited: 50
Molecularly imprinted polymer-based sensors for cancer biomarker detection
Snehasis Bhakta, Prashant Mishra
Sensors and Actuators Reports (2021) Vol. 3, pp. 100061-100061
Open Access | Times Cited: 50
Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions
Szidónia Farkas, Adrienn Szabó, Anita Hegyi, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 861-861
Open Access | Times Cited: 35
Molecular consequences of the exposure to toxic substances for the endocrine system of females
Alicja Kowalczyk, Marcjanna Wrzecińska, Ewa Czerniawska‐Piątkowska, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113730-113730
Open Access | Times Cited: 29
Soy protein, bioactive peptides, and isoflavones: A review of their safety and health benefits
Seok Tyug Tan, Seok Shin Tan, Chin Xuan Tan
PharmaNutrition (2023) Vol. 25, pp. 100352-100352
Open Access | Times Cited: 22
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles
Taahirah Boltman, Mervin Meyer, Okobi E. Ekpo
Cancers (2023) Vol. 15, Iss. 13, pp. 3388-3388
Open Access | Times Cited: 17
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107409-107409
Closed Access | Times Cited: 7
High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer
Geriolda Topi, Shakti Ranjan Satapathy, Souvik Ghatak, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Computer-Aided Ligand Discovery for Estrogen Receptor Alpha
Divya Bafna, Fuqiang Ban, Paul S. Rennie, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4193-4193
Open Access | Times Cited: 48
Tumor antigens heterogeneity and immune response-targeting neoantigens in breast cancer
Monica Benvenuto, Chiara Focaccetti, Valerio Izzi, et al.
Seminars in Cancer Biology (2019) Vol. 72, pp. 65-75
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top